HILS insider filings

Hillstream BioPharma Inc. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-13. Screen HILS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for HILS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Hillstream BioPharma Inc.

FiledFormInsiderReported transactionsSource
2023-03-134/AMILBY RANDY — Chief Executive Officer, Director, 10% ownerGrant/award (A): 515,127 (derivative) @ $0EDGAR
2023-01-044MILBY RANDY — Chief Executive Officer, Director, 10% ownerGrant/award (A): 621,795 (derivative) @ $0EDGAR
2022-07-184Appajosyula Sireesh — DirectorGift (G): 75,757 @ $0 · Gift (G): 7,576 @ $0EDGAR
2022-06-214MILBY RANDY — Chief Executive Officer, Director, 10% ownerPurchase (P): 500 @ $0.78EDGAR
2022-06-074MILBY RANDY — Chief Executive Officer, DirectorPurchase (P): 234 @ $0.68 · Purchase (P): 100 @ $0.67 · Purchase (P): 100 @ $0.67 · Purchase (P): 66 @ $0.67 · Purchase (P): 500 @ $0.70EDGAR
2022-06-024MILBY RANDY — Chief Executive Officer, DirectorPurchase (P): 1 @ $0.94EDGAR
2022-05-254MILBY RANDY — Chief Executive Officer, DirectorPurchase (P): 200 @ $0.77 · Purchase (P): 800 @ $0.79EDGAR
2022-05-234MILBY RANDY — Chief Executive Officer, DirectorPurchase (P): 500 @ $0.89 · Purchase (P): 500 @ $0.95EDGAR
2022-05-194MILBY RANDY — Chief Executive Officer, DirectorPurchase (P): 500 @ $0.92 · Purchase (P): 500 @ $0.90EDGAR
2022-04-194MILBY RANDY — Chief Executive Officer, DirectorOption exercise/expiry (X): 7,575 @ $0.31 · Option exercise/expiry (X): 7,575 @ $0.31 · Option exercise/expiry (X): 189,393 @ $0.08 · Option exercise/expiry (X): 28,408 @ $0.08 · Option exercise/expiry (X): 7,575 @ $0.31 · Option exercise/expiry (X): 7,575 (derivative) @ $0 · +4 moreEDGAR
2022-03-234Appajosyula Sireesh — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-234Bui Lynne A. — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-234Mazur Leonard L — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-01-204MILBY RANDY — Chief Executive Officer, DirectorConversion (C): 8,101 @ $3.20 · Conversion (C): 11,325 @ $3.20 · Conversion (C): 3,231 @ $3.20 · Conversion (C): 11,545 @ $3.20 · Conversion (C): 29,026 @ $3.20 · Conversion (C): 28,366 @ $3.20 · +23 moreEDGAR
2022-01-204MILBY RANDY — Chief Executive Officer, DirectorConversion (C): 14,942 @ $3.20 · Conversion (C): 23,205 @ $3.20 · Conversion (C): 406 @ $3.20 · Conversion (C): 23,187 @ $3.20 · Conversion (C): 16,528 @ $3.20 · Conversion (C): 15,824 @ $3.20 · +24 moreEDGAR
2022-01-204MILBY RANDY — Chief Executive Officer, DirectorConversion (C): 27,479 @ $3.20 · Conversion (C): 30,772 @ $3.20 · Conversion (C): 678 @ $3.20 · Conversion (C): 10,184 @ $3.20 · Conversion (C): 18,637 @ $3.20 · Conversion (C): 18,634 @ $3.20 · +22 moreEDGAR
2022-01-184Mazur Leonard L — DirectorConversion (C): 98,733 @ $3.20 · Purchase (P): 25,000 @ $4 · Conversion (C) @ $0EDGAR

Recent 8-K events — Hillstream BioPharma Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-098-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-298-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-238-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-178-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2026-06-168-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-318-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-038-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=HILS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs